The fetal specific gene LIN28B is essential for human fetal B-lymphopoiesis and initiation of KMT2A::AFF1 infant leukemia [RNA-seq]
RNA-seq (gene expression) · human · 27 samples
- What it is
- RNA-seq (gene expression)Gene activity measured by sequencing. The summary does not mention single-cell work, so this is most likely bulk: one average per sample, the usual starting point for comparing groups.
- Organism
- Homo sapiens (human)
- Samples
- 27 samples: 7 conditions, mostly in triplicateGroups are read from the sample names, not from the paper. Check the list below.
- Data you can get
- A processed table (series matrix) and supplementary files from NCBI; the raw sequencing reads from ENA. Which of these hold counts depends on the study, so check the file list.
Read the full summary ↓
Direct links to NCBI and ENA, no account and no request form. Pick by what you want to do: take the small processed table to look, the supplementary files to re-analyse, or the original raw data to start over.
Processed table
The series matrix: one table of values per sample as the submitters processed it. The smallest download, and it opens in Excel or R. Start here to see what the data look like.
Supplementary files
The count tables and other files the authors uploaded. Take only the samples you need, or the whole study as GSE295919_RAW.tar (it can run to tens of gigabytes).
Raw sequencing reads
The original FASTQ files, straight from the sequencer, held at ENA. Large, and you align them yourself, so only choose this if you need to re-process the study from scratch.
What the files usually look like: For RNA-seq the counts are usually a table among the supplementary files (look for 'counts', 'expression', 'FPKM' or 'TPM' in the file name). The series matrix of a sequencing study is sometimes nearly empty.
Also filed as BioProject PRJNA1256788 and SRA study SRP582149. Searching any of these in the dataset finder brings you back here.
Supports a between-group comparison across 23 samples.
How we read this: 7 replicated groups read from 27 sample titles; they account for 23 of them. These groups are guessed from the sample names, not taken from the paper, so check them against the sample list below before relying on them.
- GSM8960878 ABM_HSC_1 ABM_HSC
- GSM8960879 ABM_HSC_2 ABM_HSC
- GSM8960880 ABM_HSC_3 ABM_HSC
- GSM8960881 ABM_MPP_1 ABM_MPP
- GSM8960882 ABM_MPP_2 ABM_MPP
- GSM8960883 ABM_MPP_3 ABM_MPP
- GSM8960884 ABM_LMPP_1 ABM_LMPP
- GSM8960885 ABM_LMPP_2 ABM_LMPP
- GSM8960886 ABM_LMPP_3 ABM_LMPP
- GSM8960887 ABM_LMPP_4 ABM_LMPP
- GSM8960888 ABM_LMPP_5 ABM_LMPP
- GSM8960889 FL_CD34_Ctrl_1 FL_CD34_Ctrl
- GSM8960890 FL_CD34_Ctrl_2 FL_CD34_Ctrl
- GSM8960891 FL_CD34_Ctrl_3 FL_CD34_Ctrl
- GSM8960892 FL_CD34_L28BKD_1 FL_CD34_L28BKD
- GSM8960893 FL_CD34_L28BKD_2 FL_CD34_L28BKD
- GSM8960894 FL_CD34_L28BKD_3 FL_CD34_L28BKD
- GSM8960895 Xeno_1_LIN28Bhi
- GSM8960896 Xeno_2_LIN28Bhi
- GSM8960897 Xeno_3_LIN28Blow
- GSM8960898 Xeno_4_LIN28Blow
- GSM8960899 SEM_Ctrl_1 SEM_Ctrl
- GSM8960900 SEM_Ctrl_2 SEM_Ctrl
- GSM8960901 SEM_Ctrl_3 SEM_Ctrl
- GSM8960902 SEM_LIN28B_1 SEM_LIN28B
- GSM8960903 SEM_LIN28B_2 SEM_LIN28B
- GSM8960904 SEM_LIN28B_3 SEM_LIN28B
- GSE304109 RNA-seq profiling of SEM B-ALL cells silenced for KMT2A::AFF1 fusion circular RNA. 6 samples shares kmt2a, aff1
- GSE281506 Combining Menin and MEK inhibition to target poor prognosis KMT2A-rearranged RAS pathway-mutant acute myeloid leukemia 42 samples shares kmt2a, leukemia
- GSE268003 AML-PDXs Accelerate Development of Novel Drug Combinations for KMT2A-rearranged Acute Myeloid leukemia 31 samples shares kmt2a, leukemia
- GSE242963 The neuronal homeobox transcription factor HMX3 is a crucial vulnerability in MECOM-negative KMT2A::MLLT3 acute myelomonocytic leukemia 16 samples shares kmt2a, leukemia
- GSE292050 Nidogen-1, a player in KMT2A rearragned pediatric acute myeloid leukemia 12 samples shares kmt2a, leukemia
- GSE274462 ACSL4-Associated Lipid Metabolism is a Distinct Therapeutic Vulnerability in KMT2A-Rearranged Acute Myeloid Leukemia 12 samples shares kmt2a, leukemia
- GSE291525 Mechanistic Insights into the Epigenetic Regulation and Therapeutic Targeting of RET Receptor Tyrosine Kinase in KMT2A-Rearranged Pediatric Acute Myeloid Leukemia 6 samples shares kmt2a, leukemia
- GSE242956 The neuronal homeobox transcription factor HMX3 is a crucial vulnerability in MECOM-negative KMT2A::MLLT3 acute myelomonocytic leukemia [RNAseq_CD34_HSPC_ectopic_HMX3] 6 samples shares kmt2a, leukemia
Metadata from NCBI GEO, cached and refreshed periodically — the NCBI page above is authoritative. Downloads link straight to NCBI/ENA; nothing is proxied through BioTransfer.